The Defiance Daily Target 2X Long LLY ETF, with the ticker symbol LLYX, is a cutting-edge financial instrument tailored for investors looking to capitalize on the dynamic health care sector, specifically within the pharmaceuticals niche. This ETF is designed to offer twice the daily performance of its underlying index, making it an ideal choice for sophisticated investors seeking amplified exposure to the pharmaceutical market. By focusing on a sector known for its innovation and resilience, LLYX provides an opportunity to benefit from the growth and advancements in drug development, biotechnology, and healthcare solutions. With its strategic leverage, this ETF caters to those with a high-risk appetite, aiming to maximize gains from short-term market movements within the pharmaceutical industry. Whether you're looking to hedge other investments or pursue aggressive growth, the Defiance Daily Target 2X Long LLY ETF offers a unique and potent investment vehicle in the ever-evolving world of healthcare.
Defiance Daily Target 2X Long LLY ETF (LLYX) Fund Flow Chart
Defiance Daily Target 2X Long LLY ETF (LLYX) 1 year Net Flows: 19M
LLYX ETF FAQ
What was LLYX’s price range in the past 12 months?
LLYX lowest ETF price was 9.60 and its highest was 26.17 in the past 12 months.
What is the AUM of LLYX?
As of Oct 27, 2025 The AUM of LLYX is 54.56M.
Is LLYX overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does LLYX pay dividends?
LLYX does not currently pay dividends.
How many shares outstanding does LLYX have?
Currently, no data Available
Which hedge fund is a major shareholder of LLYX?
Currently, no hedge funds are holding shares in LLYX